We found that TNF-α production was increased by TRPV4 activation in MIO-M1 cells and decreased by statins, implying that statins could be therapeutic agents with neuroprotective effects for glaucoma patients, if proven by animal models, which will be our next research project. This evidence concerns the gene TRPV4 and glaucoma.